Bilateral stimulation to reduce parental stress in NICU
Pilot of the Bilateral Infant Stimulation Study (BLISS): A Parent Provided Positive-Touch Intervention Targeting Stress in the Neonatal Intensive Care Unity (NICU)
NA · Oregon Health and Science University · NCT06353243
This study tests if a new technique called bilateral alternating stimulation can help reduce stress and anxiety in parents with babies in the NICU while also improving their connection with their infants.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Sex | All |
| Sponsor | Oregon Health and Science University (other) |
| Locations | 1 site (Portland, Oregon) |
| Trial ID | NCT06353243 on ClinicalTrials.gov |
What this trial studies
This study investigates the impact of bilateral alternating stimulation (BAS) on reducing stress and anxiety in parents of infants admitted to the neonatal intensive care unit (NICU). It aims to enhance bonding between parents and their neonates through a novel intervention while monitoring physiological responses. Parents will engage in the intervention at their infant's bedside, with their stress levels assessed through surveys and vital sign data collected during the process. The study will evaluate both parental and infant stress responses before and after the intervention.
Who should consider this trial
Good fit: Ideal candidates include parents of infants admitted to the NICU who are between 34 and 43 weeks gestational age.
Not a fit: Patients who have undergone recent surgical procedures or are on psychotropic medications may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce parental stress and enhance bonding with their infants in the NICU.
How similar studies have performed: While this approach is novel, similar interventions targeting parental stress in NICU settings have shown promising results in enhancing parent-infant bonding.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * admitted to the NICU at the time of study * greater than 34 weeks gestational age and less than 43 weeks gestational age * within 4 weeks of admission to NICU at time of initial contact * have parent or legal guardian willing and able to participate in the study Exclusion Criteria: * those who are less than 3 days postop from surgical procedures * current use of psychotropic medications or medications that affect the central nervous system (CNS) * CNS anomaly.
Where this trial is running
Portland, Oregon
- Oregon Health and Science University Neonatal Intensive Care Unit — Portland, Oregon, United States (RECRUITING)
Study contacts
- Study coordinator: Emily Garavatti
- Email: garavatt@ohsu.edu
- Phone: 5034942634
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Parent-Child Relations, Preterm Birth, Stress Reaction, Hospitalism in Children, neonates, heart rate variability, bilateral stimulation, positive touch